title: [Usefulness of PSA-complex in the diagnosis of prostatic carcinoma].
abstract: OBJECTIVE
  Since its discovery as a marker for prostate cancer, there have been many attempts to enhance the diagnostic efficacy of the prostate specific antigen (PSA). Among these are the studies that analyze the behavior of different forms of serum PSA bound to different antiproteases, such as alpha-1-antichymotrypsin, which forms the complexed PSA (PSA-c). This study analyzed the utility of PSA-c to enhance specificity without altering sensitivity in comparison to total PSA (PSA-t).
  
  
  METHODS
  From September 1998 to March 1999, blood samples were obtained from 96 patients that had undergone a prostate biopsy due to a suspicion of prostate cancer. PSA-c, PSA-t (Technicon Immunol system, Bayer) and PSA-c/PSA-t ratio were analyzed in these patients.
  
  
  RESULTS
  ROC curves were plotted and the optimal cutoffs were found for which the specificity was higher for PSA-c (44.6% [CI 95%, 32-57]) versus PSA-t (35.4% [CI 95%, 25-49]) and the PSA-c/PSA-t ratio (38.5% [CI 95%, 27-51]) while maintaining a similar sensitivity index (90%). PSA-c showed similar results for other values of sensitivity.
  
  
  CONCLUSIONS
  PSA-c was found to improve specificity in comparison to PSA-t and PSA-c/PSA-t ratio. PSA-c determination could avoid unnecessary biopsies without altering sensitivity; i.e., the same number of prostate cancers will be detected.
authors.affiliation: Servicios de Análisis Clínicos, Hospital Clínico San Carlos, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Martín Vega
authors.forename: J
authors.initials: J
authors.lastname: Moreno Sierra
authors.forename: M D
authors.initials: MD
authors.lastname: Ortega Heredia
authors.forename: J A
authors.initials: JA
authors.lastname: López García-Asenjo
authors.forename: C
authors.initials: C
authors.lastname: Fernández Pérez
authors.forename: E
authors.initials: E
authors.lastname: Redondo González
authors.forename: G
authors.initials: G
authors.lastname: Bocardo Fajardo
authors.forename: R
authors.initials: R
authors.lastname: Valor Perea
authors.forename: A
authors.initials: A
authors.lastname: Silmi Moyano
authors.forename: L E
authors.initials: LE
authors.lastname: Blanco Jiménez
authors.forename: L
authors.initials: L
authors.lastname: Resel Estévez
mesh_terms: D000230:Adenocarcinoma / Q000097:blood* / Q000175:diagnosis*; D000368:Aged; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis*; D012372:ROC Curve; D012680:Sensitivity and Specificity
chemical_list: D017430:Prostate-Specific Antigen
vernacular_title: Utilidad del PSA-complex en el diagnóstico del carcinoma de próstata.